Vaishali Pharma Ltd
Ticker: VAISHALI
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
10.40
Market Cap
111.48
Debt/Equity
0.1898
ROE %
1.522
PB
1.7175
Promoter %
26.322
Pledge %
0.000
1Y Rev Growth %
15.774
5Y Rev Growth %
10.429
NP Margin %
0.802
NP Margin 5Y Avg %
3.568
Trading Reference
1M Return %
-11.010
6M Return %
-16.466
1Y Return %
-58.233
% Away 52W High
139.519
% Away 52W Low
0.971
Daily Volume
358783
Investment Verdict
Hold
Score 66/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 14/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Vaishali Pharma Ltd is currently trading near a strong support level, with recent price action indicating bullish momentum. If the stock breaks above the resistance level at ₹150, it could see an upside potential of approximately 20%. However, if it falls below the support level at ₹120, there could be a downside risk of around 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
I
Ishan Dyes and Chemicals Ltd
Ishan Dyes and Chemicals Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation, making it a risky investment at this time.
View details
R
Rungta Irrigation Ltd
Rungta Irrigation Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
S
Sir Shadi Lal Enterprises Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bengal Tea & Fabrics Ltd
Bengal Tea & Fabrics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Pattech Fitwell Tube Components Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
M
MITCON Consultancy & Engineering Services Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hilton Metal Forging Ltd
Hilton Metal Forging Ltd presents several risks, including inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
H
Hypersoft Technologies Ltd
Hypersoft Technologies Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
D
Digidrive Distributors Ltd
Digidrive Distributors Ltd faces significant challenges in growth and profitability, with a risky outlook due to market conditions and governance issues.
View details
K
Ken Enterprises Ltd
Ken Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Prithvi Exchange (India) Ltd
Prithvi Exchange (India) Ltd presents several risks with inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
V
Valencia Nutrition Ltd
Valencia Nutrition Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
K
Kohinoor Foods Ltd
Kohinoor Foods Ltd shows potential in a stable sector, but faces significant challenges in growth and profitability, making it a cautious investment.
View details
N
Nagpur Power and Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
L
LA Tim Metal & Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
B.A.G. Films and Media Ltd
B.A.G. Films and Media Ltd presents a risky investment profile due to inconsistent growth, high debt levels, and weak market sentiment.
View details
Business Overview
Vaishali Pharma Ltd is a leading Indian pharmaceutical company dedicated to delivering high-quality healthcare solutions. With a strong focus on research and development, it caters to diverse therapeutic segments, ensuring effective treatments for patients. The company is committed to innovation and sustainability, making it a trusted partner for healthcare providers and patients alike.
- Established leader in the Indian pharmaceutical sector
- Focus on quality and innovation in healthcare
- Wide range of therapeutic products
- Commitment to research and development
- Trusted by healthcare professionals and patients
- Contributes to affordable healthcare solutions in India
Investment Thesis
Vaishali Pharma Ltd stands out due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for robust long-term growth, making it an appealing choice for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Growth in digital services offers a substantial runway for revenue expansion.
- Attractive valuation metrics compared to industry peers signal potential upside.
- Robust product portfolio supports sustained market presence and competitiveness.
- Positive industry trends in pharmaceuticals bolster growth prospects.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into international markets
- Strong R&D capabilities
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Dependence on key suppliers
- Market volatility affecting stock price
Peer Perspective
Vaishali Pharma Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a sustained improvement in profitability could trigger a rerating in its valuation.
Future Outlook
Vaishali Pharma Ltd is well-positioned for growth, driven by its innovative product pipeline and expanding market presence. Successful execution and effective cost control will be crucial to realizing its full potential.
📊 Stock Investment Checklist (100 Points)
Vaishali Pharma Ltd • Updated: 2025-09-18 07:49:27
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is high.
-
10GrowthHighConsistent revenue growth observed, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Vaishali Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.